Cancer treatment

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 217/18 (2006.01) A61K 31/135 (2006.01) A61K 31/17 (2006.01) A61K 31/335 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61P 35/00 (2006.01) C07C 217/20 (2006.01) C07C 217/22 (2006.01) C07D 295/112 (2006.01)

Patent

CA 2156162

The in vivo chemotherapeutic treatment of cancer cells in a living animal is improved by first administering to the animal, a compound which inhibits normal cell proliferation while promoting malignant cell proliferation, specifically a potent antagonist selective for intracellular histamine receptors, in an amount sufficient to inhibit the binding of intracellular histamine to the receptors in normal and malignant cells. An enhanced toxic effect on the cancer cells from the chemotherapeutic agent is obtained while any adverse effect of the chemotherapeutic agent on normal cells, particularly bone marrow and gastro-intestinal cells, is inhibited. Certain fluoro derivatives useful in such procedure are novel compounds.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1492244

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.